CVE:MFS

Medifocus Inc. (MFS.V) Stock Forecast, Price & News

C$0.01
0.00 (0.00 %)
(As of 09/4/2020)
Add
Compare
Today's Range
C$0.01
C$0.01
50-Day Range
C$0.01
C$0.01
52-Week Range
C$0.01
C$0.02
Volume26,000 shs
Average Volume317,764 shs
Market CapitalizationC$1.85 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive MFS News and Ratings via Email

Sign-up to receive the latest news and ratings for Medifocus Inc. (MFS.V) and its competitors with MarketBeat's FREE daily newsletter.


About Medifocus Inc. (MFS.V)

Medifocus, Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus, Inc. is based in Toronto, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.50 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Medifocus Inc. (MFS.V) (CVE:MFS) Frequently Asked Questions

What stocks does MarketBeat like better than Medifocus Inc. (MFS.V)?

Wall Street analysts have given Medifocus Inc. (MFS.V) a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medifocus Inc. (MFS.V) wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Medifocus Inc. (MFS.V)'s key executives?

Medifocus Inc. (MFS.V)'s management team includes the following people:
  • Dr. William W. Jow, CEO, Pres & Medical Director (Age 63, Pay $180k)
  • Mr. Charkes C. Shelton, Exec. VP and Gen. Counsel (Age 75)

Who are some of Medifocus Inc. (MFS.V)'s key competitors?

What other stocks do shareholders of Medifocus Inc. (MFS.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifocus Inc. (MFS.V) investors own include (RLYP) (RLYP), Sangamo Therapeutics (SGMO), Regeneron Pharmaceuticals (REGN), Onconova Therapeutics (ONTX), Intec Pharma (NTEC), FireEye (FEYE), Chevron (CVX), BP Prudhoe Bay Royalty Trust (BPT) and Axon Enterprise (AAXN).

What is Medifocus Inc. (MFS.V)'s stock symbol?

Medifocus Inc. (MFS.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MFS."

How do I buy shares of Medifocus Inc. (MFS.V)?

Shares of MFS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Medifocus Inc. (MFS.V)'s stock price today?

One share of MFS stock can currently be purchased for approximately C$0.01.

How much money does Medifocus Inc. (MFS.V) make?

Medifocus Inc. (MFS.V) has a market capitalization of C$1.85 million and generates C$2.23 million in revenue each year.

How many employees does Medifocus Inc. (MFS.V) have?

Medifocus Inc. (MFS.V) employs 7 workers across the globe.

What is Medifocus Inc. (MFS.V)'s official website?

The official website for Medifocus Inc. (MFS.V) is www.medifocusinc.com.

Where are Medifocus Inc. (MFS.V)'s headquarters?

Medifocus Inc. (MFS.V) is headquartered at The Exchange Tower Suite 1800, 130 King Street West, PO Box 427, TORONTO, ON M5X 1E3, Canada.

How can I contact Medifocus Inc. (MFS.V)?

Medifocus Inc. (MFS.V)'s mailing address is The Exchange Tower Suite 1800, 130 King Street West, PO Box 427, TORONTO, ON M5X 1E3, Canada. The company can be reached via phone at +1-905-3197070.


This page was last updated on 6/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.